Bulls N' Bears with Matt Birney
Bulls N' Bears with Matt Birney
Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status …Social links:
Great Southern Mining: Ok so this could be serious – a screaming IP anomaly in copper-gold elephant country
Great Southern Mining: Ok so this could be serious – a screaming IP anomaly in copper-gold elephant country Listen to ASX-listed Great Southern Mining Managing Director Matt Keane talk to Matt Birney on the Bulls N’ Bears Report about why farm-in partner Gold Fields Ltd is spending millions on …
03:02
Hot Chili: A strategic land acquisition that will make this massive copper-gold project even bigger!
Hot Chili: A strategic land acquisition that will make this massive copper-gold project even bigger! Listen to ASX-listed Hot Chili Managing Director Christian Easterday talk to Matt Birney on the Bulls N’ Bears Report about a strategic land acquisition that is likely to make the largest copper-…
03:09
Javelin Minerals: Following in the golden footsteps of Spectrum and Spartan?
Javelin Minerals: Following in the golden footsteps of Spectrum and Spartan? Listen to ASX-listed Javelin Minerals Executive Chairman Brett Mitchell talk to Matt Birney on the Bulls N’ Bears Report about Javelin’s plan to emulate the spectacular successes of Spectrum Metals and Spartan Resources, …
03:07
Dateline Resources: Barrick gave up this gold project and now it will make $47m a year!
Dateline Resources: Barrick gave up this gold project and now it will make $47m a year! Listen to ASX-listed Dateline Resources Managing Director Steve Baghdadi talk to Matt Birney on the Bulls N’ Bears Report about Dateline’s scoping study on a project in the USA it snatched from Barrick Gold 3 y…
03:05
Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries
Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries Listen to ASX-listed Lithium Australia Managing Director Simon Linge talk to Matt Birney on the Bulls N’ Bears Report about Lithium Australia’s lithium battery recycling division that has …
02:28
Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior?
Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior? Listen to ASX-listed Kali Metals Managing Director Paul Adams talk to Matt Birney on the Bulls N’ Bears Report about Kali’s multimillion-dollar WA farm in deal with one of the biggest lithium miners on the planet.
03:10
Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?
Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer? Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete respon…
03:11
Xanadu Mines: A copper/gold PFS with biblical scale numbers!
Xanadu Mines: A copper/gold PFS with biblical scale numbers! Listen to ASX-listed Xanadu Mines Executive Chairman Colin Moorhead talk to Matt Birney on the Bulls N’ Bears Report about Xanadu’s crazy big pre-feasibility study numbers on its massive copper-gold play that has enough mineralisation t…
03:09
Chariot Corporation: A new scalable lithium mining strategy and a doubled share price!
Chariot Corporation: A new scalable lithium mining strategy and a doubled share price! Listen to ASX-listed Chariot Corporation Managing Director Shanthar Pathmanathan talk to Matt Birney on the Bulls N’ Bears Report about Chariot’s new plan to just build a small-scale lithium mine that can be ra…
03:06
Amplia Therapeutics: An oral cancer drug trial with serious results!
Amplia Therapeutics: An oral cancer drug trial with serious results! Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.
02:35